2007Chinese Journal of Laser Medicine & SurgeryRequires access

Intraoperative Mitomycin C in Laser Dacryoplasty

Tian Chun-ling

Open publisher page 0 citations

Abstract

Objective To assess the efficacy of mitomycin C(MMC) in Nd∶YAG laser dacryoplasty.Methods Three hundred ninety eight eyes in 308 cases with obstruction of lacrimal passage were randomly divided into MMC group and control group.In MMC group,210 eyes of 158 cases firstly applied 0.2ml MMC for 5min,then filled up antibiotic ointment.In control group,150 cases(188 eyes) filled up only antibiotic ointment without MMC.Results All patients were followed up for 6-36 months.It was found that the cure rate and effective rate of MMC group were 87.1% and 95.7%,and the rates of control group were 78.2% and 83.0% which were less than the rates of MMC group(P0.05).Conclusions Using MMC in YAG laser dacryoplasty can effectively inhibit the scar formation,and provide a higher successful rate of laser dacryoplasty.

About this research paper

What this paper is about

Objective To assess the efficacy of mitomycin C(MMC) in Nd∶YAG laser dacryoplasty.Methods Three hundred ninety eight eyes in 308 cases with obstruction of lacrimal passage were randomly divided into MMC group and control group.In MMC group,210 eyes of 158 cases firstly applied 0.2ml MMC for 5min,then filled up antibiotic ointment.In control group,150 cases(188 eyes) filled up only antibiotic ointment without MMC.Results All patients were followed up for 6-36 months.It was found that the cure rate and effective rate of MMC group were 87.1% and 95.7%,and the rates of control group were 78.2% and 83.0% which were less than the rates of MMC group(P0.05).Conclusions Using MMC in YAG laser dacryoplasty can effectively inhibit the scar formation,and provide a higher successful rate of laser dacryoplasty.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To assess the efficacy of mitomycin C(MMC) in Nd∶YAG laser dacryoplasty.Methods Three hundred ninety eight eyes in 308 cases with obstruction of lacrimal passage were randomly divided into MMC group and control group.In MMC group,210 eyes of 158 cases firstly applied 0.2ml MMC for 5min,then filled up antibiotic ointment.In control group,150 cases(188 eyes) filled up only antibiotic ointment without MMC.Results All patients were followed up for 6-36 months.It was found that the cure rate and effective rate of MMC group were 87.1% and 95.7%,and the rates of control group were 78.2% and 83.0% which were less than the rates of MMC group(P0.05).Conclusions Using MMC in YAG laser dacryoplasty can effectively inhibit the scar formation,and provide a higher successful rate of laser dacryoplasty.

Key concepts: Mitomycin C, Medicine, Laser, Surgery, Cure rate, Antibiotics, Ophthalmology, Optics

Related papers

Back to paper searchBrowse research topicsOriginal source
Intraoperative Mitomycin C in Laser Dacryoplasty — Research Paper | ScholarLens